Vanderbilt Ingram cancer Centre — Nashville, Tennessee

Vanderbilt Ingram cancer Centre is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Ingram cancer Centre has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors.

Sponsors: U3 Pharma GmbH.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Ingram cancer Centre?

Vanderbilt Ingram cancer Centre has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Ingram cancer Centre conducted?

Vanderbilt Ingram cancer Centre has 1 clinical trials on record. Their work covers Advanced Solid Tumors.

Is Vanderbilt Ingram cancer Centre accredited by Crixeo Health?

Vanderbilt Ingram cancer Centre has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Ingram cancer Centre?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.